67118-34-7 Usage
Uses
Used in Pharmaceutical Industry:
(2-Oxo-4-phenyl-pyrrolidin-1-yl)-acetic acid is used as a potential pharmacological agent for [application reason] due to its chemical structure and the class of compounds it belongs to. Its potential applications in this industry could include the development of new drugs or therapeutic agents, given the presence of the 4-phenyl pyrrolidine ring and the acetyl group, which are common structural elements in many bioactive molecules.
Used in Chemical Research:
(2-Oxo-4-phenyl-pyrrolidin-1-yl)-acetic acid is used as a research compound for [application reason] in the field of organic chemistry. Its unique structure and the presence of the 2-oxo group and acetic acid part make it an interesting subject for studies on chemical reactivity, synthesis, and potential applications in various chemical processes.
Used in Environmental Studies:
(2-Oxo-4-phenyl-pyrrolidin-1-yl)-acetic acid is used as a subject of investigation for [application reason] in environmental science. The limited information on its toxicity and environmental impact necessitates further research to understand its potential effects on ecosystems and how it may interact with other chemicals in the environment. This knowledge is crucial for assessing the safety and sustainability of its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 67118-34-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,1,1 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 67118-34:
(7*6)+(6*7)+(5*1)+(4*1)+(3*8)+(2*3)+(1*4)=127
127 % 10 = 7
So 67118-34-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H13NO3/c14-11-6-10(7-13(11)8-12(15)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,15,16)
67118-34-7Relevant academic research and scientific papers
A novel phenylpyrrolidine derivative: Synthesis and effect on cognitive functions in rats with experimental ishemic stroke
Baukov, Yuri I.,Borisevich, Sophia S.,Borozdenko, Denis A.,Chekhonin, Vladimir P.,Cherkashova, Elvira A.,Ezdoglian, Aiarpi A.,Golubev, Yaroslav V.,Gonchar, Darya I.,Gubskiy, Ilya L.,Gubsky, Leonid V.,Gureev, Maxim A.,Kiseleva, Nina M.,Lagunin, Alexey A.,Lyakhmun, Dmitri N.,Namestnikova, Daria D.,Negrebetsky, Vadim V.,Shagina, Anastasia D.,Shmigol, Tatiana A.,Tarasenko, Dmitri V.
, (2021/10/20)
We performed an in silico, in vitro, and in vivo assessment of a potassium 2-[2-(2-oxo-4-phenylpyrrolidin-1-yl) acetamido]ethanesulfonate (compound 1) as a potential prodrug for cognitive function improvement in ischemic brain injury. Using in silico meth
